Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking

<div>Compound-target network of the SZHP. The yellow circle represents genes, the aqua and light salmon colors represent the active compounds of the SZHP, and the red circle represents the common compounds of the SZHP.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking 

Figure 2 | Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking 